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Abstract
Background: Bacterial vaginosis (BV) is the single most common vaginal infection in women of childbearing age
and associated with a sizeable infectious disease burden among both non-pregnant and pregnant women, including
a significantly elevated risk of adverse pregnancy outcome. Overall, little progress has been made in identifying
causal factors involved in BV acquisition and persistence. We sought to evaluate maternal iron status in early
pregnancy as a putative risk factor for BV, considering that micronutrients, and iron deficiency in particular, affect
the host response against bacterial colonization, even in the setting of mild micronutrient deficiencies.
Methods: In a nested case-control study, we compared maternal iron status at entry to prenatal care (mean
gestational age 9.2 ± 2.6 weeks) between eighty women with healthy vaginal microflora and eighteen women with
vaginosis-like microflora. Vaginal microflora status was assessed by assigning a modified Nugent score to a Gram-
stained vaginal smear. Maternal iron status was assayed by an array of conventional erythrocyte and serum
indicators for iron status assessment, but also by more sensitive and more specific indicators of iron deficiency,
including soluble transferrin receptors (sTfR) as an accurate measure of cellular and tissue iron deficiency and the
iron deficiency log10[sTfR/ferritin] index as the presently most accurate measure of body storage iron available.
Results: We found no statistically significant correlation between vaginal microflora status and routinely assessed
iron parameters. In contrast, a highly significant difference between the healthy and vaginosis-like microflora
groups of women was shown in mean values of sTfR concentrations (1.15 ± 0.30 mg/L versus 1.37 ± 0.38 mg/L,
p = 0.008) and in mean iron deficiency log10[sTfR/ferritin] index values (1.57 ± 0.30 versus 1.08 ± 0.56, p = 0.003),
indicating a strong association between iron deficiency and vaginosis-like microflora. An sTfR concentration >1.45
mg/L was associated with a 3-fold increased risk (95%CI: 1.4–6.7) of vaginosis-like microflora and after controlling
for maternal age, gestational length, body mass, parity, and smoking habits with an adjusted odds ratio of 4.5
(95%CI: 1.4–14.2).
Conclusion: We conclude that subclinical iron deficiency, presumably resulting from inadequate preconceptional
iron supplies, is strongly and independently associated with vaginosis-like microflora during early pregnancy.
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Bacterial vaginosis (BV) is the single most common vagi-
nal infection in women of childbearing age. Basically, BV
involves a shift from the predominant hydrogen peroxide-
producing Lactobacillus species, such as L. crispatus and L.
jensenii [1-3] to a polymicrobial flora that includes gram-
variable and gram-negative anaerobes such as Gardnerella
vaginalis, Prevotella spp., and Mobiluncus spp. [4,5], and
more recently associated gram-positive anaerobes such as
Peptostreptococcus spp. [6] and Atopobium vaginae [3,7-9].
Besides a nuisance problem causing vaginal discomfort
[10], BV is also associated with a sizeable disease burden
[11]. In pregnancy, the presence of vaginosis-like micro-
flora especially during early gestation has been consist-
ently and strongly associated with spontaneous preterm
labour and preterm prelabour rupture of membranes, and
hence, BV is a major determinant to the prematurity-
related disease burden [12]. In addition, though not con-
sidered a conventionally defined sexually transmitted
infection (STI), BV strongly predisposes to the acquisition
of pandemic STIs, such as Neisseria gonorrhoeae [13],
Chlamydia trachomatis [13], and most notably HIV-1
among both pregnant [14,15] and non-pregnant women
[16-19].
A few factors are known to increase the risk of BV, includ-
ing demographic factors such as black ethnicity, and
behavioural factors including smoking, vaginal douching,
IUD contraceptive use, and sexual behaviour-related fac-
tors [20]. Overall, little progress has been made however
in identifying causal factors involved in BV acquisition
and recurrence [21,22]. In particular, there is a striking
dearth of data on intrinsic or biological risk factors for BV.
Nonetheless, since BV is not deemed a traditionally
defined STI, it is all the more likely that intrinsic factors
elicit a pivotal role in the acquisition of disturbed vaginal
microflora and, in some women, are underlying the
apparent instability of the vaginal ecosystem. In particu-
lar, it is increasingly assumed that subtle differences in the
type and magnitude of the host-pathogen response at the
level of the vaginal mucosa may explain the differential
susceptibility to perturbation of the vaginal niche [23].
Some very recent findings in the field of the innate vaginal
mucosal immune response, including the demonstration
of genetic differences, such as Toll 4-like receptor gene
mutations [24], and of phenotypic differences such as
impaired expression of anti-inflammatory cytokines [25],
being strongly correlated with the susceptibility to bacte-
rial vaginosis are unique examples to the above paradigm.
From this perspective, we hypothesized that micronutri-
ent status during early pregnancy may represent yet
another putative biological risk factor for BV, considering
that micronutrients, and iron deficiency in particular,
affect the host response against bacterial colonization
[26], even in the setting of mild micronutrient deficiencies
[27]. Moreover, maternal iron deficiency has been consist-
ently associated with adverse pregnancy outcome [28,29]
and it has therefore been reiterated that micronutrient sta-
tus during early pregnancy warrants further scrutiny even
among well-nourished women from high-income coun-
tries [28].
Methods
Study population and design
As part of a prospective cohort study basically involving
the study of vaginal microflora during early pregnancy in
relation to pregnancy outcome, we conducted a nested
case-control study comprising 115 unselected pregnant
women, which were consecutively enrolled on the occa-
sion of their first antenatal visit, between March 3 and
November 6, 2003 at the outpatient obstetric clinic of the
Ghent University Hospital. The Ghent University Hospital
Ethical Board approved the study protocol and all study
subjects agreed to participate through written informed
consent.
Sample collection
Vaginal samples were collected for the purpose of vaginal
microflora status assessment by inserting a sterile cotton-
tipped wooden swab into the vagina. The swab was rolled
round through 360 degrees against the vaginal wall at the
midportion of the vault and carefully withdrawn to pre-
vent contamination. Swabs were then smeared on a plain
glass slide and air-dried at room temperature. The slides
were Gram stained and assigned a modified Nugent score
[4] according to Ison and Hay [30]. Accordingly, Gram-
stained vaginal smears were initially categorized as nor-
mal (grade I), intermediate (grade II), and bacterial vagi-
nosis (grade III). To the purpose of the present study, we
subsequently pooled the latter two categories into a single
category unless otherwise specified, and therefore further
denote two vaginal microflora status categories: normal or
healthy microflora (corresponding to grade I microflora
or a Nugent score 0–3) and disturbed or bacterial vagino-
sis-like microflora (corresponding to grade II and III or a
Nugent score 4–10).
Blood samples were drawn within one hour following
vaginal swabbing and processed within four hours. A first
venous blood sample was allowed to clot, and centrifuged
(1000 g for 10 minutes at room temperature). The super-
natant serum was collected for analysis. Serum ferritin,
soluble transferrin receptors (sTfR), and C-reactive pro-
tein (CRP) were assayed by fixed-time immunoneph-
elometry using commercial rabbit anti-human antisera on
a BN II nephelometer (Dade Behring), calibrated against
the CRM 470 certified reference material. Serum transfer-
rin concentration was assessed by immunoturbidimetryPage 2 of 10
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(Roche Diagnostics). Serum iron concentration was meas-
ured by spectrophotometry (ferrozine method). Serum
transferrin saturation (TS) was calculated as TS (%) =
[serum iron (µmol/L)/serum transferrin (g/L)] × 3.98.
Additional indices of iron deficiency were calculated fol-
lowing log10 transformation of serum ferritin and sTfR
concentrations, including the log10 [sTfR]/log10[ferritin]
and log10 [sTfR/ferritin] indices [31]. These combined
measures have recently evolved as highly specific and sen-
sitive measures of iron deficiency [31]. In particular, the
logarithm of the ratio of the soluble transferrin receptor to
ferritin concentration (log10 [sTfR/ferritin]) is currently
the most precise measure of body storage iron available
[32,33].
A second venous blood sample was simultaneously col-
lected in EDTA tubes to assess plasma haemoglobin
(Hgb), red blood cell count (RBC) and haematocrit (Hct),
mean corpuscular volume (MCV) and mean corpuscular
haemoglobin (MCH) (Sysmex SE-9500; Toa Medical
Electronics).
All women had a vaginal ultrasound (US) scan and if
embryonal biometry was inconsistent with the calculated
gestational length, the latter was adjusted according to US
biometry. Body mass index or BMI (kg/m2) was calculated
as weight (kg)/[length (m)] 2 after standardized assess-
ment of maternal weight and length at entry to prenatal
care. All other clinical data were collected in a routine
manner.
Exclusion criteria
Exclusion criteria were first attendance beyond fourteen
completed weeks of gestation, multiple gestation, and
pre-existing maternal systemic disease, e.g. diabetes melli-
tus. Women who were unacquainted with the Dutch lan-
guage could not be included because we had no means to
obtain informed consent from these in a proper way.
Definitions
For initial assessment of subjects, iron deficiency and
anaemia were defined according to the WHO criteria of
serum ferritin ≤ 12 g/L and haemoglobin < 11 g/dL,
respectively. Iron deficiency was further investigated by
the use of more sensitive indicators, in particular maternal
sTfR concentrations and the log10 [sTfR/ferritin] index;
however, no reference values for pregnant women are
available at present for these parameters.
Statistical analyses
Following the one-sample Kolmogorov-Smirnov test pro-
cedure for each variable, we established that all continu-
ous variables could be analysed under the parametric
assumption (p-value to the Z-statistic >0.5), except mater-
nal serum CRP. Means are presented as arithmetic means
and standard deviation to the mean. Means between two
groups were compared with the independent samples t
test. Strength of bivariate correlations was expressed as
Pearson correlation coefficients (R). Strength of associa-
tion was calculated as prevalence or risk ratios (RR) in a
univariate analysis and (adjusted) odds ratios (OR) in a
multivariable analysis with 95% confidence intervals (CI)
and p-values to the 95% CI. Multivariable analysis was
performed using a stepwise binary logistic regression
model and likelihood ratio tests were used to compare dif-
ferent models. For any reported measure, statistical signif-
icance was accepted, as the two-tailed probability level
was <0.05.
All statistical analyses were performed using the statistical
software package SPSS v12.0 (Chicago, Illinois).
Results
Study population
We excluded seventeen women (17/115 or 14.8%) who
had given their consent for participation in the study,
from the analysis, because they refused part of the sam-
pling procedure, or because of incomplete or inadequate
sampling, including delay between vaginal and blood
sampling, or because of early (missed) abortion. As a
group, the subjects excluded did not differ significantly
from the remainder of women in terms of baseline char-
acteristics (mean maternal age, mean body mass index,
smoking habits, mean gestational age, and median parity
and gravidity).
From each patient included for the final analysis (98/115
or 85.2%) a vaginal swab and venous blood samples were
obtained at a single point in time at a mean gestational
age of 9.2 ± 2.6 weeks. Eighty women had normal or grade
I microflora on Gram stain and eighteen women pre-
sented with disturbed or vaginosis-like microflora, i.e.
intermediate (grade II) microflora or overt bacterial vagi-
nosis (grade III) microflora.
Basic clinical characteristics of study participants, who
were all of white Caucasian origin, are displayed in table
1. Women with disturbed vaginal flora in the index preg-
nancy were significantly more likely to have delivered a
child previously and tended to have a higher body mass
index (Table 1).
Traditional indicators of iron deficiency in relation to 
vaginal microflora status
In this study sample, 10.2% of subjects (10/98) had
depleted iron stores during early pregnancy according to
the conventional criterion of serum ferritin ≥ 12 g/L. 4.1%
of women (4/98) presented with anaemia defined as HgbPage 3 of 10
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g/dL (10/98), though only one of these (1/98 or 1.0%)
had true iron-deficient anaemia when accounting for both
serum ferritin (≥ 12 g/L) and haemoglobin (< 11 g/dL).
Any other traditional compound indices of iron-defi-
ciency, e.g. by accounting for mean cell volume, mean cor-
puscular haemoglobin, and transferrin saturation did not
identify any additional cases of clinical overt iron
deficiency.
There was no statistically significant correlation between
vaginal microflora status as assessed by Gram stain and
any of the conventionally assessed iron and red blood cell
indices, including red blood cell counts, serum haemo-
globin, haematocrit, mean corpuscular volume, mean
corpuscular haemoglobin, serum iron, serum ferritin,
serum transferrin and transferritin saturation (Table 2).
Similarly, we observed no significant association between
vaginal microflora status and maternal CRP concentration
Table 1: Basic clinical characteristics of the study population.
Healthy vaginal microflora (n = 80) Disturbed vaginal microflora (n = 18) p-value
Maternal age (years) – mean ± SD 30.5 ± 4.7 30.2 ± 5.7 0.8
Gestational age (weeks) – mean ± SD 9.3 ± 2.6 8.7 ± 2.8 0.4
Body mass index (kg/m2) – mean ± SD 22.7 ± 4.0 24.9 ± 5.8 0.05
Body mass index (kg/m2) – % (n)
<25 77.5% (62) 50.0% (9) 0.04
≥25 22.5% (18) 50.0% (9)
Parity – % (n)
0 43.8% (35) 16.7% (3) 0.04
≥1 56.3% (45) 83.3% (15)
Gravidity – % (n)
0 35.0% (28) 11.1% (2) 0.05
≥1 65.0% (52) 88.9% (16)
Smoking – % (no)
Yes 11.1% (2) 22.2% (4) 0.1
No 88.9% (16) 77.8% (14)
Healthy vaginal flora is defined as grade I or lactobacilli-dominated microflora on Gram stain (corresponding to a Nugent score 0 – 3) and disturbed 
vaginal flora is defined as grade II and grade III flora, this is mixed or gram-negative rods-dominated microflora on Gram stain (corresponding to a 
Nugent score ≥4). Body mass index (BMI) refers to the BMI at entry to prenatal care and is calculated as weight (kg)/[length (m)]2.
Table 2: Maternal serum iron and red blood cell indices according to vaginal microflora status. Healthy vaginal flora is defined as grade 
I or lactobacilli-dominated microflora on Gram stain (corresponding to a Nugent score 0 – 3) and disturbed vaginal flora is defined as 
grade II and grade III flora, this is mixed or gram-negative rods-dominated microflora on Gram stain (corresponding to a Nugent score 
≥4). RBC denotes red blood cell counts, Hgb plasma haemoglobin concentration, Hct hematocrit, MCV mean corpuscular volume of 
red blood cells, MCH mean corpuscular haemoglobin mass of red blood cells, Fe serum iron concentration, and sTfR (serum) soluble 
transferrin receptor concentration, respectively.
Healthy vaginal microflora (n = 80) Disturbed vaginal microflora (n = 18) p-value
RBC (×106/µL) 4.3 ± 0.4 4.4 ± 0.4 0.5
HgB (g/dL) 13.1 ± 0.9 13.1 ± 1.1 0.8
Hct (%) 38.8 ± 2.6 39.4 ± 3.2 0.4
MCV (fL) 89.4 ± 4.6 89.1 ± 5.3 0.8
MCH (pg/cell) 30.2 ± 1.8 29.7 ± 1.5 0.3
Fe (µg/dL) 113.0 ± 39.1 105.2 ± 43.3 0.5
Ferritin (mg/L) 46.2 ± 35.9 52.5 ± 56.6 0.6
Transferrin (mg/dL) 2.8 ± 0.5 2.9 ± 0.5 0.7
Transferrin saturation (%) 29.5 ± 12.1 26.7 ± 12.3 0.4
sTfR (mg/L) 1.15 ± 0.30 1.37 ± 0.38 0.01
Log10[sTfR]/log10[ferritin] 0.04 ± 0.12 0.10 ± 0.15 0.04
Log10[sTfR/ferritin] 1.57 ± 0.30 1.08 ± 0.56 0.003Page 4 of 10
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of overt systemic inflammation according to maternal
CRP, nor were ferritin and transferrin concentrations sig-
nificantly correlated with CRP.
Soluble transferrin receptors in relation to vaginal 
microflora status
In contrast to the above, we observed a trend by which
maternal serum transferrin receptor (sTfR) concentrations
during early pregnancy were negatively correlated with
lactobacillary grading and hence positively correlated
with the degree of vaginal microflora alteration (R = 0.26,
p = 0.01). When vaginal microflora status was handled as
a dichotomous variable ('healthy' versus 'disturbed'),
women with healthy vaginal microflora (n = 80) during
early pregnancy had a mean sTfR concentration of 1.15 ±
0.30 mg/L as compared to a mean sTfR of 1.37 ± 0.38 mg/
L among women (n = 18) with disturbed microflora (p =
0.008) (Figure 1).
Given the significant overlap in sTfR distributions for the
healthy and disturbed vaginal microflora groups of
women, classification plots were constructed and the sTfR
value with the highest discriminative value between both
groups was chosen as the sTfR cut-off level. Serum trans-
ferrin receptor concentrations > 1.45 mg/L were associ-
ated with a prevalence or risk ratio of 3.0 (95% CI: 1.4 –
6.7, p = 0.014) for disturbed vaginal flora. The accuracy of
the sTfR assay at this threshold was 79% (95% CI: 0.69–
0.86). Sensitivity and the positive predictive value (PPV)
were however low and estimated at 39% (95% CI: 0.18–
0.64) and 41% (95% CI: 0.19–0.67), respectively. In con-
trast, specificity and consequently the negative predictive
value (NPV) of the assay were as high as 88% (95% CI:
0.78–0.94) and 86% (95% CI: 0.77–0.93), respectively.
Of the parameters entered into in the multivariable anal-
ysis only smoking, body mass index and gravidity/parity
were expected to act as true confounders of the association
under study considering these variables impinge both on
serum transferrin receptor concentrations and on vaginal
microflora status. We also controlled for maternal age,
gestational age at sampling, and CRP as covariates in the
model. Yet, the only significant variable retained from the
multivariable analysis was the maternal sTfR concentra-
tion, suggesting that raised sTfR concentrations during
early pregnancy are independently associated with vaginal
microflora alteration. The adjusted odds ratio of an sTfR-
concentration > 1.45 mg/L for vaginosis-like vaginal
microflora was 4.5 (95%CI: 1.4–14.2, p = 0.011).
The log10 [sTfR/ferritin] iron deficiency index in relation to 
vaginal microflora status
Since sTfR concentrations may reflect both rates of eryth-
ropoiesis as well as cellular iron needs, several combined
measures following log transformation of sTfR and/or fer-
ritin have been used as highly specific and sensitive meas-
ures of iron deficiency in particular, including sTfR/
log10[ferritin], log10[sTfR]/log10[ferritin], and log10[sTfR/
ferritin] [31].
The logarithm of the ratio of the soluble transferrin recep-
tor to ferritin concentration (log10 [sTfR/ferritin]) is cur-
rently the most precise measure of body storage iron
available [32,33]. We found a highly significant difference
(difference in means = 0.49, 95% CI 0.30–0.68, p <
0.0001) between mean values of the log10 [sTfR/ferritin]
index (1.57 ± 0.30 versus 1.08 ± 0.56) between both
groups (Table 2) further indicating that the observed asso-
ciation between maternal sTfR concentrations and vaginal
microflora status indeed relates to depleted available
body iron stores and cellular iron avidity.
Though our sample size was rather small, post hoc analy-
sis revealed that the above difference in the mean iron
deficiency index values (log10[sTfR/ferritin]) between
both groups was demonstrated at a two-sided significance
Distribution of sTfR concentrations according to vaginal m croflora statusFigure 1
Distribution of sTfR concentrations according to vag-
inal microflora status. Box-and-whisker plots of the sTfR 
distributions according to vaginal microflora status during 
early pregnancy. The thick line represents the median sTfR 
value, the horizontal box lines the 25th percentile and 75th 
percentile, and the outer short horizontal lines the bounda-
ries of the sTfR range. Healthy vaginal flora is defined as 
grade I or lactobacilli-dominated microflora on Gram stain 
(corresponding to a Nugent score 0 – 3) and disturbed vagi-
nal flora is defined as grade II and grade III flora, this is mixed 
or gram-negative rods-dominated microflora on Gram stain 
(corresponding to a Nugent score ≥4).Page 5 of 10
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(1-β = 92.7) under the parametric assumption and by
accounting for unequal variances.
Supplemental iron intake as a potential determinant of 
iron indices
Of note is that 65.3% of women in this cohort (64/98)
were already taking oligo-elements or vitamin supple-
ments at the time of sampling, most often as combined
preparations (35/98 or 35.7%) or as folate supplements
(27/98 or 27.6%). We found no significant association
between iron supplementation (37/98 or 37.8%) and
maternal sTfR concentrations (p = 0.95) or with the com-
bined sTfR-ferritin indexes following log transformation
(p = 0.20 to 0.97), while there was a marginally significant
association between serum ferritin concentrations and
supplemental iron intake (p = 0.053).
Discussion
The association of subclinical iron deficiency with 
vaginosis-like microflora
We found that maternal serum concentrations of soluble
transferrin receptors during early pregnancy were posi-
tively correlated with decreased lactobacillary grading and
hence with degree of vaginal microflora alteration. An
sTfR concentration above 1.45 mg/L, this is approximately
one SD (0.33 mg/L) above the mean sTfR concentration
(1.19 mg/L), was associated with a 3-fold increased risk of
vaginosis-like microflora (RR = 3.0, 95%CI: 1.4–6.7), and
the risk did not change when accounting for potential dif-
ferences in the distributions of maternal age, gestational
age, body mass index, parity, CRP, and smoking habits.
Albeit sTfR is considered a marker of both iron status and
erythropoiesis, sTfR acts as a marker of erythropoiesis only
when iron stores are adequate and sTfR additionally
becomes a marker of iron status in the setting of tissue
iron deficiency with or without adequate iron stores [31].
In this cohort of pregnant women, the sTfR distribution
among women presenting with disturbed vaginal flora
was significantly skewed to the right partly in the absence
of overt iron deficiency as measured by serum ferritin. We
therefore accounted for the log10 [sTfR/ferritin] index,
which is considered the most accurate measure of body
storage iron available [32,33] and documented a highly
significant difference in the log10 [sTfR/ferritin] distribu-
tions between the normal and disturbed vaginal micro-
flora groups of women. We therefore believe that the
observed risk of vaginosis-like microflora associated with
increased sTfR concentrations can reliably be attributed to
insufficiently available body storage iron and cellular or
tissue iron deficiency during early pregnancy.
Documenting the association between iron and vaginal 
microflora status during pregnancy depends on the 
accuracy of the iron assays applied
Serum transferrin receptor synthesis is up-regulated in
iron-deprived tissues and it can therefore be argued that
assessment of iron status at the tissue level is of more func-
tional importance when examining the effects of iron
depletion on disease occurrence than conventional assess-
ment of iron stores. Several recent studies have shown that
sTfR is a very sensitive and specific index of iron deficiency
during pregnancy [34,35], that sTfR assaying is superior to
conventional methods for the assessment of iron status
[32,33] and that the accuracy with which iron deficiency
can be diagnosed is further increased by combining sTfR
and ferritin [31-33]. In contrast, conventional indicators
of iron status, such as red blood cell indices and markers
of iron transport tend to be less sensitive or are altered by
gestation independently of iron status [31,34], and there-
fore also have low specificity. Markers of iron storage and
transport, ferritin and transferrin, may also act as acute
phase reactants which may further intricate the interpreta-
tion of their values with regard to iron status, though there
was no evidence of confounding by inflammation in our
study.
Consequently, it may not be surprising that the array of
conventional iron and red blood cell assays that were per-
formed in our study did not pick up the association with
vaginal microflora status. Ferritin is however, a very early
marker in the setting of inadequate iron supplies and
could therefore reasonably be expected to reflect the
observed association as well, though not obvious from
this study. A possible explanation is that our study lacked
the power to demonstrate the effect of iron deficiency as
assessed by ferritin alone, due to its biological variability,
considering serum ferritin shows a wide range of values
within the normal range.
If anything, it cannot be ignored that when accounting for
both ferritin and soluble transferrin receptor concentra-
tions in the log10 [sTfR/ferritin] index as an established
highly accurate measure of body storage iron, the differ-
ence between the healthy and disturbed vaginal micro-
flora groups of women became even more apparent than
when accounting for sTfR alone.
Iron deficiency in early pregnancy may ensue from critical 
preconceptional iron supplies which are further 
compromised by iron restriction during early pregnancy
Soluble transferrin concentrations have been shown to be
steadily low during early pregnancy [31,34,36,37] and rel-
atively decreased as compared to prepregancy concentra-
tions by some [31] or at least not significantly elevated
from the non-pregnant state until the second trimester by
others [37]. This has been attributed to bluntedPage 6 of 10
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poiesis [36] with low peripheral reticulocyte counts dur-
ing the first pregnancy trimester [37].
Decreased erythropoiesis has in turn been considered to
concur with decreased iron requirements during early
pregnancy due to cessation of menstrual losses [38]. Yet,
the biological significance of this relative erythropoietic
quiescence has not been fully explained.
It is likely that the disproportionate increases in maternal
plasma volume and red cell mass leading to the physio-
logic anaemia of pregnancy from early gestation until
term represent an important hemodynamic and hemo-
static protective feature of normal pregnancy [39]. Several
studies have demonstrated unfavourable pregnancy out-
comes associated with high Hgb concentrations early in
pregnancy, as well as in situations where Hgb concentra-
tions fail to decline in the mid-trimester [40]. Conse-
quently, the relative erythropoietic slowdown during early
pregnancy might be targeted at rapid enhancement of
such hemodilution. For instance, by the end of the first tri-
mester, maternal plasma volume has expanded by some
15% on average [41], though not paralleled by a concom-
itant boost in erythropoietin release [36], as would be
expected [42].
Of note is that intestinal iron absorption during the first
trimester is also reduced [38], while rapidly increasing
after that time with the amount of dietary iron transferred
to the foetus regulated in response to maternal iron status
at the level of the gut [43]. It is therefore plausible that
restrictive iron absorption during early pregnancy at the
time of critical processes such as placental development
and organogenesis also concurs with other protective
mechanisms, notably anti-oxidant and anti-infectious
defence [28,40].
Against this background, it is conceivable that women
entering pregnancy with impending iron deficiency may
share a conflict of interest between these potentially pro-
tective iron- and erythropoiesis-restricting mechanisms
on one hand, and insufficient iron availability to comply
with increased basic metabolic rates and increased iron
and oxygen demands on the other hand. It has been rec-
ognized that the high gestational iron needs during the
second and third trimesters are met by increasing intesti-
nal iron absorption rates beyond the first trimester up to
term, but also by mobilizing available prepregnancy
reserves [34]. High STfR concentrations during early preg-
nancy among a subset of women in this cohort may there-
fore reflect cellular iron deficiency as a result of subclinical
or latent prepregnancy iron shortage.
Iron deficiency and the host response against vaginal 
bacterial colonization
As it comes down to the biological plausibility of the
observed association, it is conceivable that iron deficiency
may affect both innate and cellular immune responsive-
ness [26,27] at the level of the vaginal mucosa, though we
did not identify any previous study on micronutrient sta-
tus and bacterial vaginosis. The significant association of
iron deficiency anaemia with infection has however exten-
sively been demonstrated and most importantly, these
effects have been attributed to the adverse effects of iron
deficiency on the immune system, even in the setting of
mild micronutrient deficiencies [26,27,29]. Interestingly,
our observations on the association between iron defi-
ciency and bacterial vaginosis concur with the consistent
association between maternal iron deficiency in early
pregnancy and a greater risk of preterm delivery [28,29]
on one hand, and with the strong and consistent associa-
tion between bacterial vaginosis in early pregnancy and
preterm delivery [11,12,20] on the other hand.
Limitations of the study
Our results should be taken with caution considering our
sample size was limited. Therefore our findings undenia-
bly need to be confirmed in much larger, prospective
cohort studies, preferably including non-pregnant women
as well. Though the present case-control study was actu-
ally nested within a larger cohort study, failure to consist-
ently follow-up patients enrolled at entry to prenatal care
hampered any further conclusions being drawn that
might be of interest to our results presented above.
As to confounding, we were able to control for most estab-
lished confounders that may impinge on vaginal micro-
flora status and on sTfR concentrations, including age,
gestational length, BMI, smoking habits, and parity.
Among these body mass index and parity warrant particu-
lar scrutiny, considering these variables were significantly
associated with vaginal microflora status in our series,
while also being known determinants of maternal sTfR
concentrations. Maternal sTfR concentrations were how-
ever not significantly correlated with BMI (p = 0.4). The
correlation between sTfR and parity was also not apparent
from our data, this is, when parity was handled as the raw,
categorical variable (p = 0.2), yet the correlation became
highly significant when parity was handled as a binary
variable (0.005). Therefore, it cannot be ignored that the
observed association between maternal sTfR concentra-
tions and vaginal microflora status concurs with the asso-
ciation between sTfR and parity. In particular, we found
that multiparous women had on average a significantly
higher sTfR (p = 0.003) and were also significantly more
likely to have disturbed vaginal microflora (p = 0.04) as
compared to nulliparous women. Though these interac-
tions were cancelled in the multivariable analysis by thePage 7 of 10
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still needs to be considered that parity may act as a con-
founder to the former association. If anything, as it is only
plausible that parity affects mean sTfR rather than sTfR
concentrations determining parity, the most conceivable
explanation would be that sTfR concentrations are the
explanatory variable to the association between parity and
vaginal microflora status. Ethnicity was not a confounder
to our study as all women were of white Caucasian origin.
We did not collect any data on sexual behaviour-related
characteristics nor on vaginal douching, which have con-
sistently been associated with BV, and therefore it cannot
be precluded that differential sexual behaviour and differ-
ences in use of vaginal hygiene products between both
groups may have confounded our results at least to some
extent.
It should also be acknowledged that, owing to the design
of the study, we are also unaware of the timing of the
exposure relative to the timing of the outcome. There is
good evidence from the literature however, that the sTfR
concentrations at these early gestational ages most likely
reflect preconceptional sTfR concentrations, as discussed
above.
Finally, at the sTfR cut-off level chosen, the strength of the
association was convincingly strong and this was further
reflected by the high specificity and the high NPV indicat-
ing that above this threshold, women with disturbed
vaginal microflora were overrepresented among subjects
with a high sTfR and hence with impaired iron availability
or tissue iron needs. On the contrary, though subjects
with sTfR concentrations below the threshold represented
the preponderance of women with normal vaginal micro-
flora, a substantial proportion of the women with dis-
turbed vaginal microflora also had no evidence of iron
deficiency, and therefore the sensitivity and the PPV were
actually low. This observation is not unexpected to the
extent BV – much alike most conditions, is thought of as
a multifactorial condition that obviously can occur in the
absence of iron deficiency.
Iron supplementing and bacterial vaginosis: an 
opportunity for preconceptional prevention of adverse 
pregnancy outcome?
We could not establish a significant relationship between
iron supplementing and various indicators of iron
deficiency in this population with the exception of a mar-
ginally significant association with ferritin values, but this
finding should be taken with caution considering we had
no information on duration of iron supplementing pre-
ceding iron status assessment. However, since study sub-
jects were enrolled at their first antenatal visit, the time
span between commencement of iron supplementing and
iron status assessment must have been rather short. If any-
thing, our study lacked the power to substantiate such an
association considering the prevalence of iron deficiency
was fairly low and rates of supplemental iron intake rather
high. Previous studies did demonstrate a significant
decrease of sTfR concentrations following iron adminis-
tration among both pregnant [34] and non-pregnant sub-
jects [44].
From the above notions on iron metabolism in early preg-
nancy it may be inferred however, that adequate precon-
ceptional iron stores and therefore preconceptional iron
supplementing rather than first trimester supplements
may better serve the goal of preventing BV-associated
adverse pregnancy outcome and preterm birth in particu-
lar. Of note is that in animal models, preconceptional
nutrional status has recently also been associated with
non-infectious preterm birth [45].
Conclusion
We conclude that subclinical iron deficiency, presumably
resulting from inadequate preconceptional iron supplies,
is strongly and independently associated with vaginosis-
like microflora during early pregnancy, after accounting
for maternal age, gestational length, body mass index,
parity, CRP, and smoking habits as potential confounders.
The strong association between tissue iron deficiency with
vaginosis-like flora during early pregnancy was docu-
mented by assessment of highly sensitive and specific
markers, in particular maternal soluble transferrin recep-
tors and the log10 [sTfR/ferritin] iron deficiency index,
while the association was not apparent from conventional
iron and red blood cell indicators.
These findings need to be confirmed in larger, prospective
cohort studies, preferably including non-pregnant women
as well. If so, the association of latent, subclinical or func-
tional iron deficiency with bacterial vaginosis may be of
paramount interest to the primary and secondary preven-
tion of bacterial vaginosis and bacterial vaginosis-associ-
ated disease, including preterm birth.
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